Patents by Inventor Avram Lev Robinson-Mosher

Avram Lev Robinson-Mosher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11014973
    Abstract: Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface multisubunit signaling receptors (e.g., EGFRvIII-expressing cells that also express interferon receptors) and that induce anti-proliferative effects, and related compositions and methods for the treatment of cancer.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: May 25, 2021
    Assignee: President and Fellows of Harvard College
    Inventors: Jeffrey Charles Way, Avram Lev Robinson-Mosher
  • Publication number: 20200291085
    Abstract: Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface multisubunit signaling receptors (e.g.
    Type: Application
    Filed: November 26, 2019
    Publication date: September 17, 2020
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Jeffrey Charles Way, Avram Lev Robinson-Mosher, Thomas M. Roberts, Jean Zhao
  • Patent number: 10538566
    Abstract: Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface multisubunit signaling receptors (e.g., EGFRvIII-expressing cells that also express interferon receptors) and that induce anti-proliferative effects, and related compositions and methods for the treatment of cancer.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: January 21, 2020
    Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Jeffrey Charles Way, Avram Lev Robinson-Mosher
  • Publication number: 20190233492
    Abstract: Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface multisubunit signaling receptors (e.g.
    Type: Application
    Filed: April 5, 2019
    Publication date: August 1, 2019
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Jeffrey Charles Way, Avram Lev Robinson-Mosher, Thomas M. Roberts, Jean Zhao
  • Patent number: 10308697
    Abstract: Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface multisubunit signaling receptors (e.g., EGFRvIII-expressing cells that also express interferon receptors) and that induce anti-proliferative effects, and related compositions and methods for the treatment of cancer.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: June 4, 2019
    Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Jeffrey Charles Way, Avram Lev Robinson-Mosher
  • Publication number: 20170051030
    Abstract: Aspects of the disclosure provide fusion proteins that bind cells expressing one or more target molecules including, for example, one or more cell surface multisubunit signaling receptors (e.g., EGFRvIII-expressing cells that also express interferon receptors) and that induce anti-proliferative effects, and related compositions and methods for the treatment of cancer.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Applicants: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.
    Inventors: Jeffrey Charles Way, Avram Lev Robinson-Mosher, Thomas M. Roberts, Jean Zhao